ELSE Nutrition Toddler Products to Launch in Over 380 U.S. Retail
Locations in November 2020
ELSE
rapidly expands distribution to provide nationwide product
availability in retail, Amazon.com and Else's e-store
VANCOUVER,
British Columbia, Canada -- October 28, 2020 -- InvestorsHub
NewsWire -- ELSE NUTRITION HOLDINGS
INC. (TSX-V: BABY)
(OTCQX:
BABYF)
(FSE:
0YL)
("Else"
or the "Company"),
a
commercial
stage developer of
plant-based alternatives to dairy-based baby nutrition,
is pleased
to provide an update on upcoming
availability of the Company's products in U.S. retail
stores.
The
Company expects to begin its initial store distribution via
KeHE
Distributors
in western and southern regions of the United States as early as
late November 2020, and is to include up four regional accounts and
one national key account, totaling 380 stores in advance of the
Christmas season.
U.S. Retail Distribution and Rollout
Following
the recent successful e-store and Amazon launch for its plant-based
toddler nutrition line, Else has been working diligently through
its network of retail brokers and KeHE
Distributors
on strategic 'Brick & Mortar' account listings across various
critical US regions.
"We are
very encouraged with the aggressive interest we have received for
our product. Parents and families have waited a long time for a
plant-based alternative to dairy-based baby
nutrition.
Soon
parents across the United States will be able to find our product
at stores near them in addition to being able to order online,"
said Mrs. Hamutal Yitzhak, CEO and Co-Founder of Else.
About
Else Nutrition Holdings Inc.
Else
Nutrition GH Ltd. is an Israel-based food and nutrition company
focused on developing innovative, clean and plant-based food and
nutrition products for infants, toddlers, children, and adults. Its
revolutionary, plant-based, non-soy, formula is a clean-ingredient
alternative to dairy-based formula. Else Nutrition (formerly INDI)
won the "2017 Best Health and Diet Solutions" award at the Global
Food Innovation Summit in Milan. The holding company, Else
Nutrition Holdings Inc., is a publicly traded
company, listed as TSX Venture Exchange under the trading symbol
BABY and is quoted on the US OTC Markets QX
board under the trading symbol BABYF and on the Frankfurt Exchange
under the symbol 0YL. Else's Executives
includes leaders hailing from leading
infant nutrition companies. Many of Else advisory
board
members had
past executive roles in companies such as Mead Johnson, Abbott
Nutrition, Plum Organics and leading infant nutrition
Societies,
and some of
them currently serve in different roles in leading medical centers
and academic institutes such as Boston Children's Hospital,
Pediatrics at Harvard Medical School, USA, Tel Aviv University,
Schneider Children's Medical Center of Israel, Rambam Medical
Center and Technion, Israel and University Hospital Brussels,
Belgium.
For more
information, visit: elsenutrition.com or
@elsenutrition on Facebook and Instagram.
For more information, contact:
Ms.
Hamutal
Yitzhak, CEO, Co-Founder & Director
ELSE
Nutrition Holdings Inc.
E:
hamutaly@elsenutrition.com
P:
+972(0)3-6445095
Mr. Sokhie
Puar, Director of Else Nutrition
Email:
sokhiep@elsenutrition.com
Telephone:
604-603-7787
TSX Venture Exchange
Neither
the TSX Venture Exchange nor its regulation services provider (as
that term is defined in the policies of the TSX Venture Exchange)
accepts responsibility for the adequacy or accuracy of this
release.
Caution Regarding Forward-Looking Statements
This
press release contains statements that may
constitute
"forward-looking statements" within the meaning of applicable
securities legislation. Forward-looking statements are typically
identified by words such as "will" or similar expressions.
Forward-looking statements in this press release include
statements
with respect to the
anticipated
dates for filing the Company's financial disclosure
documents.
Such
forward-looking statements reflect current estimates, beliefs and
assumptions, which are based on management's perception of current
conditions and expected future developments, as well as other
factors management believes are appropriate in the circumstances.
No assurance can be given that the foregoing will prove to be
correct. Forward-looking
statements made in this press release assume, among others,
the expectation
that there
will be no interruptions or supply chain failures as a result of
COVID 19 and that the manufacturing, broker and supply logistic
agreement with the Company do not terminate.
Actual
results may
differ
from the estimates, beliefs and assumptions expressed or implied in
the forward-looking statements.
Readers
are cautioned not to place undue reliance on any forward-looking
statements, which reflect management's expectations only as of the
date of this press release. The Company disclaims any obligation to
update or revise any forward-looking statements, whether as a
result of new information, future events or otherwise, except as
required by law.